Robert Dahl

Robert Dahl is currently the Director at Sprout Pharmaceuticals, Inc. Robert joined the company in 2018. Prior to that, they worked as the Director at Cancer Research Institute (CRI) starting in 2012. In the same year, they also became the Managing Director at WRD Capital. From 2009 to 2012, they were the COO at Arrowhawk Capital Partners. Robert's earlier experience includes working at The Carlyle Group as the Head of Healthcare Investing from 1999 to 2006. Before that, they were the Head of Healthcare Investment Banking at Credit Suisse First Boston from 1986 to 1999.

Robert Dahl received their Bachelor of Arts degree in Economics from Middlebury College between 1974 and 1978. Robert then pursued their Master of Business Administration degree at Harvard Business School from 1981 to 1983.